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ABSTRACT
Objectives: To explore whether daytime napping and
sleep duration are linked to serum C reactive protein
(CRP), a pro-inflammatory marker, in an older aged
British population.
Design: Cross-sectional study.
Setting: European Prospective Investigation into
Cancer and Nutrition (EPIC)-Norfolk study.
Participants: A total of 5018 men and women aged
48–92 years reported their sleep habits and had serum
CRP levels measured.
Outcome and measures: CRP was measured
(mg/L) during 2006–2011 in fresh blood samples
using high-sensitivity methods. Participants reported
napping habits during 2002–2004, and reported sleep
quantity during 2006–2007. Multivariable linear
regression models were used to examine the
association between napping and log-transformed CRP,
and geometric mean CRP levels were calculated.
Results: After adjustment for age and sex, those who
reported napping had 10% higher CRP levels compared
with those not napping. The association was attenuated
but remained borderline significant (β=0.05 (95% CI
0.00 to 0.10)) after further adjustment for social class,
education, marital status, body mass index, physical
activity, smoking, alcohol intake, self-reported health,
pre-existing diseases, systolic blood pressure, hypnotic
drug use, depression and in women-only hormone
replacement therapy use. The geometric means (95% CI)
of CRP levels were 2.38 (2.29 to 2.47) mg/L and 2.26
(2.21 to 2.32) mg/L for those who reported napping and
no napping, respectively. A U-shaped association was
observed between time spent in bed at night and CRP
levels, and nighttime sleep duration was not associated
with serum CRP levels. The association between napping
and CRP was stronger for older participants, and among
extremes of time spent in bed at night.
Conclusions: Daytime napping was associated with
increased CRP levels in an older aged British population.
Further studies are needed to determine whether daytime
napping is a cause for systemic inflammation, or if it is a
symptom or consequence of underlying health problems.
INTRODUCTION
Recently there has been growing interest in
studying the health implications of daytime
napping. Although the beneﬁts of napping
on wakefulness performance have been
widely documented, especially among shift
workers,1 a few studies also reported an
increased health risk associated with daytime
napping. Speciﬁcally, daytime napping has
been associated with increased mortality,2 3
cardiovascular4 and diabetes risk.5 We have
recently found a 32% increased mortality
risk among those who napped for ≥1 h/day
in a middle to older aged British popula-
tion.6 While it is not yet clear whether
daytime napping is a cause or symptom of
the increased health risk, examination of the
physiological correlations of napping will
help to gain understanding of the napping–
health relationship.
One important proposed pathway for the
association between sleep and health out-
comes is through inﬂammation.7 C reative
protein (CRP), a general marker for inﬂam-
mation, was ﬁrst suggested to increase after
sleep deprivation in an experimental study.8
Since then, there have been increasing
numbers of observational studies which pro-
duced mixed ﬁndings on the association.
Long sleep duration has been associated with
increasing CRP among men,9 women10 as
well as in the sexes combined sample,11 12
with long sleep being brought up as a poten-
tial marker of underlying inﬂammatory
illness.11 By contrast, Miller et al13 found an
association between short sleep duration and
increased CRP only in women. Taheri et al14
suggested no signiﬁcant association between
Strengths and limitations of this study
▪ Our study benefits from a large population-based
sample, measures of daytime as well as
nighttime sleep, and a wide range of covariates
available for adjustment.
▪ Sleep habits were self-reported.
▪ The purpose and duration of napping was not
reported, and sleep apnoea was not measured.
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CRP levels and sleep duration in the Wisconsin Sleep
Cohort Study.
Despite the growing interest into the inﬂammatory
correlates of nighttime sleep, there has been limited evi-
dence on the physiological effects of daytime napping.
Experimental study has reported a beneﬁcial effect of
napping on immune cells following acute sleep restric-
tion.15 However, habitual daytime napping as a lifestyle
might relate to different physiological effects compared
with napping as a form of recovery sleep, and under-
standing the link between habitual napping and inﬂam-
mation could help to clarify the association observed for
napping and the increased mortality risk. Moreover, a
number of changes in sleep from middle to older adult-
hood have been reported, including an advanced circa-
dian pacemaker, decreased sleep efﬁciency and
increased daytime sleepiness.16–18 Therefore we set out
to examine the associations between daytime napping
and serum CRP levels in the European Prospective
Investigation into Cancer (EPIC)-Norfolk cohort,
a middle to older aged British population. In addition,
we have previously reported the different implications
between sleep duration and time spent in bed,19 so con-
ﬁrmatory analysis was also conducted to test the associa-
tions separately for sleep duration and time spent in bed
at night. Given the gender disparity suggested by some
previous studies,13 20 we explored sex differences in the
associations.
METHODS
Participants
The design and study methods of EPIC-Norfolk have
been described previously.21 Brieﬂy, 25 639 men and
women were recruited into the EPIC-Norfolk study
during 1993–1997 using general practice age–sex regis-
ters, and attended the baseline health check. These par-
ticipants were then followed up for two further health
examinations from 1996 to 2000 and from 2006 to 2011.
In between these health examinations, participants were
sent questionnaires for completion and returned by
post. The Norwich District Ethics Committee approved
the study and all participants gave signed informed
consent.
Sleep measures
Habitual daytime napping was ascertained during 2002–
2004, by asking participants the question “Do you nor-
mally take a nap during the day?”
‘Nighttime sleep duration’ and ‘Time spent in bed at
night’ were ascertained during 2006–2007, by asking par-
ticipants “On average, about how many hours have you
slept each night?”; “At what time do you normally get
up?” and “At what time do you normally go to bed?”.
‘Time spent in bed’ was derived from the differences
between rise time and bedtime, and as a weighted mean
measure of weekday and weekend times (5/7×(time on
a weekday)+2/7×(time on a weekend day)).
C reactive protein
CRP was measured (mg/L) at the third health examin-
ation (2006–2011) in fresh blood samples using
high-sensitivity methods using the Siemens Dimension
clinical chemistry analyser (Newark, Delaware, USA),
with between-batch coefﬁcient of variation (CV) values of
3.1% at 7.86 mg/L and 3.7% at 88.75 mg/L.
Covariates
Covariates measured closer in time to each measure of
sleep were chosen and included in the models for the
corresponding sleep measures. The covariates were
chosen as a priori based on their link with CRP and
sleep.19 22 Social class (professionals, managerial and
technical occupations, skilled workers subdivided into
non-manual and manual, partly skilled workers and
unskilled manual workers) and education (highest quali-
ﬁcation attained: no qualiﬁcations, educated to age 16,
educated to age 18 and educated to degree level) were
assessed at the baseline questionnaire. Body mass index
(BMI; weight in kilograms divided by height in metres
squared) and systolic blood pressure (SBP; mm Hg)
were objectively assessed through the health examin-
ation. The other covariates reported by questionnaires
included: marital status (single, married, widowed, sepa-
rated and divorced), physical activity (inactive, moder-
ately inactive, moderately active and active23), smoking
status (current, former and non-smokers), alcohol
intake (units of alcohol drunk per week), self-reported
general health (excellent, good, moderate or poor),
major depressive disorder (MDD; yes/no), pre-existing
diseases (including self-reported stroke, myocardial
infarction, diabetes, cancer, asthma, bronchitis and
emphysema), use of hypnotic drugs (yes/no) and
hormone replacement therapy (HRT) use.
Statistical analysis
Analysis was restricted to those participants with com-
plete data on all covariates. A total of 5018 participants
had complete data on CRP and at least one of the sleep
measures, and were included in the analysis.
The CRP values were natural-log transformed (loge CRP)
to approximate a normal distribution. Owing to the
U-shaped relationship reported by previous studies on sleep
duration and health risk,24 25 and in order to retain sufﬁ-
cient numbers, sleep duration was categorised into three
categories (<6, 6–8 and >8 h) and time spent in bed was
categorised into four categories (<6, 6–8, 8–10 and >10 h).
Multivariable linear regression models using loge CRP as
the outcome were conducted to examine the associations
between each sleep measure (daytime napping (N=4712),
time spent in bed (N=4476) and sleep duration (N=4795))
and CRP levels. For each sleep variable, results were pre-
sented: (A) adjusted for age and sex; (B) further adjusted
for social class, education and marital status, BMI, physical
activity, smoking and alcohol intake, depression, self-
reported health, pre-existing diseases, SBP, hypnotic drug
use and in women-only postmenopausal HRT. The sleep
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measures were mutually adjusted in model B. Since the
associations for sleep duration and time spent in bed might
be non-linear (approximately U-shaped), the β coefﬁcients
(with 95% CIs) were calculated with 6–8 h being the refer-
ence groups for the examination of sleep quantitative mea-
sures. For analysis by napping habit, the no napping
category was chosen as reference group. Results were pre-
sented for the whole sample and for men and women
separately.
Geometric—mean (95% CI) of serum CRP values
(mg/L) were calculated by exponentiating crude and
adjusted-least square mean (95% CI) loge CRP values.
Finally, subgroup analysis was conducted for the main
sleep variables of interest, napping and time spent in
bed at night, to explore the effects of potential effect
modiﬁers (including age, sex, social class, smoking,
BMI, physical activity and pre-existing diseases). These
analyses were adjusted for age, sex, social class, educa-
tion, marital status and BMI. The two-by-two interactions
between napping habit, time spent in bed and sleep dur-
ation were examined using the likelihood ratio test.
Sensitivity analysis: all statistical tests were two-sided, and
a p value <0.05 was considered statistically signiﬁcant.
Analyses were implemented in STATAV.12.0.
RESULTS
Characteristics of the study sample (2267 men and 2751
women) are shown in table 1. The mean age of the parti-
cipants was 69.5 (ranging from 48 to 92) years old. More
than 60% of the sample came from non-manual social
class, and 48% were former or current smokers. A total of
38.5% men and 23.1% women reported daytime
napping. The average time people spent in bed every
night was 8.6±0.8 h and the average sleep duration was
6.9±1.1 h. Serum CRP ranged from 0.1 to 116.6 mg/L,
with a median of 2.0 mg/L (IQR 2.07 mg/L).
The unadjusted geometric means of CRP were 2.53
(2.44 to 2.63) and 2.20 (2.15 to 2.26) mg/L for those
who reported napping and no napping, respectively.
Table 2 shows differences in loge CRP according to the
report of napping. After adjustment for age and sex,
daytime napping was associated with 10% higher CRP
levels (β=0.10, 95% CI (0.05 to 0.15), p<0.001). With
further adjustment for socioeconomic status,
health-related behaviours, physical health and nighttime
sleep, the association was attenuated but remained bor-
derline signiﬁcant (β=0.05, 95% CI (0.00 to 0.10),
p=0.048). Table 3 shows the multivariable-adjusted geo-
metric means of CRP. The geometric means of CRP
levels were 2.38 (2.29 to 2.47) and 2.26 (2.21 to 2.32)
mg/L for those who reported napping and no napping,
respectively. When analyses were stratiﬁed by sex, the
associations between the above napping measure and
CRP levels were only signiﬁcant among women.
The unadjusted geometric means of CRP for those
who reported spending <6, 6–8, 8–10 and >10 h in bed
at night were 3.70 (2.48 to 5.53), 2.25 (2.15 to 2.35),
2.29 (2.23 to 2.35) and 2.84 (2.52 to 3.19) mg/L,
respectively. After adjustment for age and sex, spending
<6 and >10 h in bed were associated with 51% and 17%
increase in CRP levels, respectively (table 2). After full
adjustments, long time spent in bed was associated with
12% increase in CRP levels while the association
between short time spent in bed and loge CRP was not
signiﬁcant. The geometric means of CRP levels among
those who spent >10 and <6 h in bed were 2.57 (2.30 to
2.87) and 3.00 (2.04 to 4.40) mg/L, respectively, higher
than those who spent 6–8 h in bed (2.28 (2.19 to 2.38)
mg/L). Nighttime sleep duration was not associated
with loge CRP. Repeating the analyses restricted to indivi-
duals with CRP levels below 10 mg/L did not change
the results.
Subgroup analysis investigated differences in these
associations by age, sex, social class, smoking, BMI, phys-
ical activity and pre-existing diseases (table 4). These
data suggested that the association between napping
and CRP levels was stronger for those who were older as
compared with those who were younger (p for inter-
action=0.007). In addition, the association was more pro-
nounced for extremes of time spent in bed at night
(p for interaction=0.01; ﬁgure 1).
DISCUSSION
Our ﬁndings from more than 4000 middle to older aged
English adults suggest that daytime napping was inde-
pendently associated with higher CRP levels. Those who
reported napping had 10% higher CRP levels after
adjustment for age and sex. The association was attenu-
ated but remained statistically signiﬁcant after adjust-
ment for all the covariates. A U-shaped association was
observed between time spent in bed at night and CRP
levels, though only the effect of long time spent in bed
was statistically signiﬁcant. The napping–CRP associa-
tions were more pronounced among extremes of time
spent in bed at night. No association was found between
sleep duration and CRP levels.
To the best of our knowledge, this is the ﬁrst study to
report an association between habitual daytime napping
and inﬂammation. This gives biological insights to the
health impact of daytime napping proposed by previous
studies.3 26 Our study beneﬁts from a large population-
based sample, and a wide range of covariates available
for adjustment. Although only moderate effect size was
detected in the multivariable model, the possibility of
over adjustment cannot be excluded, given the complex-
ity of the relationship between sleep and health. Overall,
this preliminary ﬁnding at population level provides an
interesting perspective and implies the need for further
physiological studies. There are several limitations.
Similar to most previous population studies,26 27 daytime
napping was self-reported as yes or no. It was suggested
that power naps (naps <30 min) can be largely beneﬁ-
cial,1 28 while naps >30 min can cause sleep inertia and
are not recommended.29 Without detailed report of
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napping duration, we were unable to differentiate the
effects of power naps from excessive napping. Other
sleep disorders (eg, sleep apnoea) that might have led
to daytime sleepiness were not assessed, so the possibility
of residual confounding by these sleep disorders cannot
be ruled out. Moreover, reported sleep may be a marker
of distress levels,30 which has been linked with CRP
levels.31 However, evaluation of sleep in the primary care
setting relies on self-reported data from patients, and
also the association remained after adjustment for MDD.
Another limitation of this study is that associations are
based on a single measurement of CRP. However, the
intraindividual variability of CRP measurements is
similar to that of other physiological measures such as
blood pressure and cholesterol levels, and a single meas-
urement of CRP has been shown to predict a range of
health outcomes.32 33 Besides, previous study has
reported no diurnal variation of CRP concentrations.34
Notably, while the assessment of napping preceded the
CRP measures, baseline CRP level was not measured
and there is no information on changes in CRP over
time. We were therefore unable to distinguish between
Table 1 Baseline characteristics of the EPIC-Norfolk participants
Men Women Total
Age (years) 70.5 (8.0) 68.6 (7.9) 69.5 (8.0)
Social class
Non-manual 1495 (66.5%) 1885 (69.3%) 3380 (68.0%)
Manual 753 (33.5%) 836 (30.7%) 1589 (32.0%)
Education
Lower 686 (30.3%) 1148 (41.7%) 1834 (36.6%)
Higher 1580 (69.7%) 1602 (58.3%) 3182 (63.4%)
Marital status
Single 60 (2.8%) 99 (3.8%) 159 (3.3%)
Married 1929 (90.4%) 2017 (77.6%) 3946 (83.4%)
Others 144 (6.8%) 484 (18.6%) 628 (13.3%)
Smoking
Current smoker 147 (6.5%) 194 (7.1%) 341 (6.8%)
Former smoker 1178 (52.1%) 881 (32.1%) 2059 (41.2%)
Never smoked 936 (41.4%) 1666 (60.8%) 2602 (52.0%)
Physical activity
Inactive 624 (29.0%) 677 (25.9%) 1301 (27.4%)
Moderately inactive 534 (24.9%) 877 (33.6%) 1411 (29.6%)
Moderately active 497 (23.1%) 613 (23.5%) 1110 (23.3%)
Active 493 (23.0%) 447 (17.1%) 940 (19.7%)
BMI (kg/m2) 26.7 (3.1) 26.0 (4.0) 26.3 (3.6)
SBP (mm Hg) 134.9 (16.9) 129.9 (17.3) 132.2 (17.3)
Alcohol (units) 8.0 [3.0–15.0] 3.0 [1.5–8.0] 5.0 [2.0–11.0]
Pre-existing diseases
No 2095 (97.5%) 2499 (98.9%) 4594 (98.2%)
Yes 53 (2.5%) 29 (1.1%) 82 (1.8%)
Hypnotic use
No 2236 (98.6%) 2717 (98.8%) 4953 (98.7%)
Yes 31 (1.4%) 34 (1.2%) 65 (1.3%)
MDD in the last year
No 1964 (97.1%) 2336 (94.3%) 4300 (95.6%)
Yes 58 (2.9%) 142 (5.7%) 200 (4.4%)
Self-reported general health
Excellent 443 (19.7%) 564 (20.6%) 1007 (20.2%)
Good 1549 (68.8%) 1828 (66.8%) 3377 (67.7%)
Moderate 245 (10.9%) 332 (12.1%) 577 (11.6%)
Poor 15 (0.7%) 11 (0.4%) 26 (0.5%)
Napping
No 1309 (61.5%) 1986 (76.9%) 3295 (69.9%)
Yes 819 (38.5%) 598 (23.1%) 1417 (30.1%)
Time spent in bed (h) 8.5 (0.9) 8.7 (0.8) 8.6 (0.8)
Sleep duration (h) 7.0 (1.1) 6.9 (1.1) 6.9 (1.1)
CRP (mg/L) 1.9 [1.3–3.2] 2.0 [1.3–3.5] 2.0 [1.3–3.4]
Results were presented as mean (SD), median [IQR] and the rest N (%).
BMI, body mass index; CRP, C reactive protein; MDD, major depressive disorder; SBP, systolic blood pressure.
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napping as a risk factor for, or as an early marker of,
increased inﬂammatory levels. Finally, the current ana-
lysis was restricted to the 5018 participants with com-
plete data on CRP and at least one of the sleep
measures. Compared with the other participants from
the baseline cohort (N=25 639), the present sample
were 4 years younger, more likely to be of higher social
class and higher education levels. Therefore, our ﬁnd-
ings have limited generalisability to populations with
lower socioeconomic status.
The present study suggested that daytime napping and
long time spent in bed at night were associated with
higher CRP levels. The observed effect size was similar
to previous report on sleep duration and CRP levels,10
and the increase in CRP levels associated with napping
was similar to that associated with 5-year increase in
age.22 While there are no other studies with which to
directly compare our ﬁndings, the current study is in
line with existing evidence on the increased cardiovascu-
lar, metabolic and mortality risks among those who take
naps, found both by other studies and in our study
population.5 6 35 36 Meanwhile, a Greek cohort study
suggested that siesta might help to reduce coronary mor-
tality through a stress-releasing mechanism in healthy
working men.37 We also found the association between
daytime napping and increased CRP levels only signiﬁ-
cant among participants over 70 years old when analysis
was stratiﬁed by age. Daytime napping might have differ-
ent implications for health among different age groups,
and this needs to be considered by future studies.
Notably, daytime napping or daytime sleepiness has
been associated with the occurrence of degenerative dis-
eases such as Parkinson’s disease and dementia in the
older population.38 39 It has also been reported that
chronic inﬂammation, as indicated by an elevation in
plasma interleukin 6 levels, was predictive of future
Parkinson’s disease.40 In the current study, daytime
napping was associated with a higher serum CRP level,
while information on other inﬂammatory biomarkers
was not obtained. Future studies with more complete
measures of chronic inﬂammation might help to clarify
the link between daytime napping and degenerative dis-
eases in the elderly. Several studies suggested that the
association between sleep and inﬂammation was only
observed in women.13 20 Consistent with these ﬁndings,
the association between napping and increased CRP
levels was only signiﬁcant in women, although test for
interaction was not statistically signiﬁcant. The reason
for this is unclear, and the gender disparities of sleep
physiology need further exploration.
Time spent in bed was rarely studied in relation to
CRP concentrations, but long sleep duration has been
associated with increased CRP levels.9 11 Since epidemi-
ology studies have used mixed ways to deﬁne sleep dur-
ation, the associations between long sleep and
inﬂammation found by some previous studies might
actually reﬂect the effects of long time spent in bed,
which was associated with poor general health.19 Indeed,
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long time spent in bed has been associated with poorer
general health, pre-existing health problems and more
frequent use of sleep medications in the EPIC-Norfolk
cohort.19 Therefore, the observed association between
long time spent in bed and increased CRP levels might
be explained by declining health status. We found no
association between sleep duration and CRP levels. This
is consistent with ﬁndings from the Wisconsin Sleep
Cohort Study, which showed no association between
CRP and sleep duration, measured objectively as well as
subjectively.14 Meanwhile, previous studies have found
short as well as long sleep duration to be associated with
increased CRP levels.13 14 Recently, a longitudinal study
suggested that each hour per night decrease in sleep
duration was associated with 8.1% higher average levels
of CRP over a 5-year period.41 The different correlations
with serum CRP levels between the two sleep quantity
measures need to be considered by future studies.
Interestingly, the association between napping and CRP
levels was more pronounced among extremes of time
spent in bed. It is possible that extremes of time spent
in bed at night partly reﬂected disturbed nighttime
sleep, and thereby added to the association for daytime
napping. While the complex inter-relationship between
nighttime and daytime sleep is yet to be conﬁrmed, the
present study suggested a need for a thorough consider-
ation of nighttime and daytime sleep in future studies.
It has been suggested that sleep deprivation is related to
the activation of the autonomic nervous system and
increased catecholamines, and subsequently stimulate the
release of inﬂammatory mediators.42 It is unclear biologic-
ally why daytime napping was associated with increased
levels of inﬂammatory markers. One possible explanation
is through a rise in blood pressure or heart rate on awaken-
ing from a nap, which might be followed by increased
endothelial shear stress and the production of inﬂamma-
tory mediators.43 Alternatively, daytime napping could be
the consequence of unnoticed nighttime sleep disturb-
ance (eg, sleep apnoea) or sleep deprivation, which have
been linked with systemic inﬂammation.42 44 45 Sleep
apnoea was not measured in the current study, but the
association between daytime napping and serum CRP
levels remained after adjustment for BMI and SBP, two
strong correlates of sleep apnoea.
In the UK, daytime napping is not part of the cultural
norm. It is plausible that those who reported daytime
napping and long time spent in bed may represent a
population with underlying ill health, and inﬂammation
could be an early sign of these health problems.
Although the association between daytime napping and
CRP concentrations remained after adjustment for pre-
existing diseases, we did ﬁnd it more pronounced
among the older participants, and there might be more
existing health problems among this population.
Further studies are needed to determine whether
daytime napping is a cause for systemic inﬂammation, or
if it is a symptom or consequence of disturbed sleep at
night or underlying health problems.
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Table 4 The association between loge CRP and napping or time spent in bed at night, by subgroups
Napping (reference: no) Time spent in bed at night (reference: 6–8 h)
Yes 0–6 h 8–10 h >10 h
β (95% CI) β (95% CI) β (95% CI) β (95% CI)
Age p for interaction=0.007 p for interaction=0.66
<70 0 (−0.06 to 0.06) 0.14 (−0.25 to 0.52) 0 (−0.06 to 0.06) 0.16* (0.01 to 0.32)
>70 0.09** (0.02 to 0.15) 0.02 (−0.59 to 0.63) 0.03 (−0.05 to 0.11) 0.12 (−0.04 to 0.28)
Sex p for interaction=0.87 p for interaction=0.82
Men 0.04 (−0.02 to 0.11) 0.07 (−0.40 to 0.53) −0 (−0.08 to 0.06) 0.16 (−0.03 to 0.35)
Women 0.05 (−0.01 to 0.11) 0.15 (−0.33 to 0.62) 0.02 (−0.04 to 0.08) 0.1 (−0.04 to 0.23)
Social class p for interaction=0.38 p for interaction=0.31
Higher 0.03 (−0.03 to 0.08) 0.15 (−0.27 to 0.57) 0.01 (−0.05 to 0.06) 0.19** (0.05 to 0.33)
Lower 0.07 (−0.01 to 0.14) 0.08 (−0.45 to 0.61) 0 (−0.08 to 0.09) 0 (−0.18 to 0.19)
Smoking p for interaction=0.5 p for interaction=0.55
Current or former smokers 0.01 (−0.05 to 0.08) 0.12 (−0.33 to 0.57) −0 (−0.10 to 0.05) 0.12 (−0.04 to 0.29)
Never smoked 0.06* (0.01 to 0.12) 0.11 (−0.37 to 0.60) 0.03 (−0.03 to 0.09) 0.11 (−0.04 to 0.26)
BMI p for interaction=0.73 p for interaction=0.30
Lower 0.06 (−0.00 to 0.12) −0.15 (−0.76 to 0.46) 0.04 (−0.03 to 0.10) 0.18* (0.02 to 0.34)
Higher 0.07* (0.01 to 0.14) 0.36 (−0.05 to 0.77) −0 (−0.10 to 0.04) 0.09 (−0.07 to 0.25)
Physical activity p for interaction=0.48 p for interaction=0.41
Inactive 0.06* (0.00 to 0.12) 0.28 (−0.14 to 0.71) 0.02 (−0.04 to 0.08) 0.13 (−0.00 to 0.26)
Active 0.02 (−0.05 to 0.09) −0.13 (−0.65 to 0.38) −0 (−0.10 to 0.05) 0.08 (−0.14 to 0.29)
Pre-existing diseases p for interaction=0.05 p for interaction=0.08
Yes 0.05 (−0.25 to 0.35) NA 0.19 (−0.19 to 0.56) 0.81** (0.21 to 1.41)
No 0.05* (0.01 to 0.10) 0.11 (−0.23 to 0.45) 0.02 (−0.03 to 0.07) 0.08 (−0.04 to 0.20)
The model adjusted for age, sex, social class, education, marital status and BMI.
Results were presented as β coefficients of linear regression models using loge CRP as the outcome.
*p<0.05 ** p<0.01 ***p<0.001.
BMI, body mass index; CRP, C reactive protein.
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CONCLUSIONS
In summary, we found for the ﬁrst time that daytime
napping was associated with increased CRP levels in a
population-based middle to older aged English cohort.
The association between daytime napping and CRP
levels was more pronounced among older people, and
among those who spent extremes of time in bed at
night. While the present study provides new insights into
the biological effects of daytime napping, causality
cannot be established from an observational study.
Daytime napping might be useful as an independent
indicator of people who are at underlying health risk or
who suffer from disturbed sleep at night. Future physio-
logical studies are needed to gain better understanding
of the association.
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